21-04-2008 Latest Results - Q1 2008
Novartis reports higher sales and earnings in first quarter of 2008 showing healthcare portfolio well on the way to new growth cycle
Novartis on track in 2008:
- Net sales from continuing operations up 9% (+0% in local currencies) to
USD 9.9 billion with double-digit contributions from Sandoz, Vaccines and Diagnostics and Consumer Health - Operating income rises 7% to USD 2.5 billion, supporting major investments in new product launches, pipeline and emerging markets
- Net income up 10% to USD 2.3 billion; EPS advances 15% to USD 1.02
